共 262 条
[1]
Younossi ZM(2016)Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84
[2]
Koenig AB(2020)Nonalcoholic fatty liver disease 2020: the state of the disease Gastroenterology 158 1851-1864
[3]
Abdelatif D(2021)Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population Liver Int 41 1290-1293
[4]
Fazel Y(2019)Non-alcoholic fatty liver disease — a global public health perspective J Hepatol 70 531-544
[5]
Henry L(2020)A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement J Hepatol 73 202-209
[6]
Wymer M(2017)Osteoporosis Ann Intern Med 167 17-32
[7]
Cotter TG(2014)The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine J Bone Miner Res 29 2520-2526
[8]
Rinella M(2010)Osteoporosis and osteomalacia Rheum Dis Clin North Am 36 665-680
[9]
Ciardullo S(2018)The combined effect of nonalcoholic fatty liver disease and metabolic syndrome on osteoporosis in postmenopausal females in eastern China Int J Endocrinol 2018 2314769-2089
[10]
Perseghin G(2020)Comparison of MAFLD and NAFLD diagnostic criteria in real world Liver Int 40 2082-1153